Q BioMed Inc. (QBIO)
OTCMKTS: QBIO · Delayed Price · USD
0.0005
+0.0001 (25.00%)
Jul 25, 2024, 4:00 PM EDT - Market closed
Q BioMed Income Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Year Ending | TTM | Nov 30, 2022 | Nov 30, 2021 | Nov 30, 2020 | Nov 30, 2019 | Nov 30, 2018 | 2017 - 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.21 | 0.28 | 0.2 | 0.03 | - | - | Upgrade
|
| Revenue Growth (YoY) | -22.67% | 45.38% | 551.99% | - | - | - | Upgrade
|
| Cost of Revenue | 0.22 | 0.29 | 0.25 | 0.33 | - | - | Upgrade
|
| Gross Profit | -0.01 | -0.01 | -0.05 | -0.3 | - | - | Upgrade
|
| Selling, General & Admin | 2.65 | 3.31 | 6.26 | 10.97 | 4.48 | 5.78 | Upgrade
|
| Research & Development | 0.06 | 0.13 | 1.07 | 1.88 | 3.54 | 3.24 | Upgrade
|
| Operating Expenses | 2.71 | 3.44 | 7.34 | 12.85 | 8.02 | 9.02 | Upgrade
|
| Operating Income | -2.73 | -3.45 | -7.39 | -13.15 | -8.02 | -9.02 | Upgrade
|
| Interest Expense | -1.25 | -1.38 | -0.51 | -0.3 | -1.46 | -0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.65 | 3.42 | -0.3 | -0.02 | -0.21 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | -0.32 | -1.41 | -8.2 | -13.46 | -9.69 | -9.27 | Upgrade
|
| Other Unusual Items | -0.17 | -0.64 | -0.04 | -0.03 | -0.59 | - | Upgrade
|
| Pretax Income | -0.49 | -2.05 | -8.24 | -13.49 | -10.28 | -9.27 | Upgrade
|
| Net Income | -0.49 | -2.05 | -8.24 | -13.49 | -10.28 | -9.27 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1.42 | 1.44 | 0.5 | 0.86 | - | - | Upgrade
|
| Net Income to Common | -1.91 | -3.49 | -8.74 | -14.35 | -10.28 | -9.27 | Upgrade
|
| Shares Outstanding (Basic) | 65 | 45 | 27 | 22 | 15 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 65 | 45 | 27 | 22 | 15 | 14 | Upgrade
|
| Shares Change (YoY) | 130.36% | 67.13% | 20.84% | 47.34% | 9.50% | 31.23% | Upgrade
|
| EPS (Basic) | -0.03 | -0.08 | -0.33 | -0.65 | -0.68 | -0.67 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.08 | -0.33 | -0.65 | -0.68 | -0.67 | Upgrade
|
| Free Cash Flow | 2.18 | 1.94 | -4.3 | -6.23 | -4.11 | -6.45 | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.04 | -0.16 | -0.28 | -0.27 | -0.47 | Upgrade
|
| Gross Margin | -6.02% | -3.16% | -26.20% | - | - | - | Upgrade
|
| Operating Margin | -1302.56% | -1211.74% | -3777.44% | -43818.05% | - | - | Upgrade
|
| Profit Margin | -231.77% | - | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 1041.64% | 682.75% | -2199.44% | -20778.14% | - | - | Upgrade
|
| EBITDA | -2.68 | -3.4 | -7.34 | -13.1 | -7.97 | - | Upgrade
|
| D&A For EBITDA | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | - | Upgrade
|
| EBIT | -2.73 | -3.45 | -7.39 | -13.15 | -8.02 | -9.02 | Upgrade
|
Source: S&P Capital IQ. Standard template.